Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ANO-2, a novel cyclic peroxide, shows multifunctional antiangiogenic and antitumor activity

Aug. 14, 2002

VNP-40101M enters phase I trial in leukemia

Aug. 13, 2002

OC-1012 completes phase I trial

Aug. 13, 2002

Second phase I study of huN901-DM1 under way

Aug. 13, 2002

Cancer targets selected from Exelixis and Bristol-Myers Squibb collaboration

Aug. 13, 2002

First in vitro study of P80DOX-NP completed

Aug. 12, 2002

Targeted Genetics restructures

Aug. 12, 2002

Biomed-101 phase Ib enrollment completed

Aug. 12, 2002

Initial phase I results for Large Scale Biology's personalized NHL vaccines

Aug. 12, 2002

ProlX receives SBIR grant to advance HIF inhibitor cancer therapy

Aug. 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...